What is Akido Labs?
Akido Labs is pioneering a reimagined healthcare system with artificial intelligence at its core. The company focuses on transforming the clinical experience by integrating sophisticated machine learning models with human-centric care delivery. By empowering both providers and patients through a novel healthcare model, Akido Labs addresses critical inefficiencies in traditional medical systems. Its technology stack is designed to unlock actionable insights from complex clinical data, thereby improving patient outcomes and operational workflows across the healthcare continuum. As the industry shifts toward digital-first care, Akido Labs remains at the forefront of this transition, providing the necessary tools to bridge the gap between legacy systems and future-ready medical services.
How much funding has Akido Labs raised?
Akido Labs has raised a total of $85.3M across 3 funding rounds:
Debt
$350K
Series A
$25M
Series B
$60M
Debt (2020): $350K with participation from PPP
Series A (2021): $25M led by Necessary Ventures
Series B (2025): $60M supported by Oak HC/FT, GrECo International, Future Communities Capital, Y Combinator, and Snr Investments
Key Investors in Akido Labs
Oak HC/FT
A premier venture growth-equity fund specializing in healthcare information and financial services technology, focused on driving industry transformation through strategic counsel and board-level participation.
Necessary Ventures
A versatile venture capital firm that invests across multiple stages, providing founders with resources to attract talent and enhance growth through extensive media networks.
Future Communities Capital
An investment firm dedicated to empowering founders who are disrupting legacy industries by providing both capital and strategic guidance to facilitate long-term success.
What's next for Akido Labs?
With the successful closure of this major strategic investment, Akido Labs is well-positioned to accelerate its market expansion and deepen its technological capabilities. The capital will likely be deployed to scale its AI infrastructure, expand its footprint within enterprise healthcare networks, and refine its clinical decision-support tools. As the company moves into this next phase of growth, the focus will shift toward achieving widespread adoption of its healthcare model, ensuring that its AI-driven solutions become a standard component of the modern clinical environment. The backing from high-profile investors provides not only the necessary liquidity but also the strategic guidance required to navigate the complexities of the global healthcare market.
See full Akido Labs company page
